Change Healthcare Financial Statements (CHNG)
|
|
|
|
Report date
|
|
|
04.06.2020 |
27.05.2021 |
29.07.2021 |
31.03.2022 |
26.05.2022 |
|
04.08.2022 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
196.8 |
3 090 |
3 090 |
3 481 |
3 481 |
|
3 609 |
|
Operating Income, bln rub |
|
|
-711.2 |
100.1 |
100.1 |
136.8 |
225.5 |
|
195.5 |
|
EBITDA, bln rub |
? |
|
-1 003 |
1 433 |
690.2 |
907.3 |
907.3 |
|
1 402 |
|
Net profit, bln rub |
? |
|
-947.6 |
-112.2 |
-112.2 |
-57.4 |
-154.6 |
|
-77.4 |
|
|
OCF, bln rub |
? |
|
-153.9 |
586.2 |
586.2 |
696.9 |
696.9 |
|
1 121 |
|
CAPEX, bln rub |
? |
|
13.0 |
246.4 |
246.4 |
276.3 |
276.3 |
|
518.8 |
|
FCF, bln rub |
? |
|
-166.9 |
339.8 |
339.8 |
420.6 |
420.6 |
|
602.4 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
246.9 |
1 505 |
1 505 |
3 344 |
3 344 |
|
2 606 |
|
Cost of production, bln rub |
|
|
84.1 |
1 532 |
1 532 |
0.000 |
0.000 |
|
833.6 |
|
R&D, bln rub |
|
|
11.6 |
227.0 |
227.0 |
277.9 |
277.9 |
|
293.0 |
|
Interest expenses, bln rub |
|
|
16.7 |
245.2 |
245.2 |
234.2 |
234.2 |
|
227.7 |
|
|
Assets, bln rub |
|
|
10 107 |
10 113 |
10 113 |
9 932 |
9 932 |
|
9 637 |
|
Net Assets, bln rub |
? |
|
3 285 |
3 252 |
3 252 |
3 276 |
3 276 |
|
3 291 |
|
Debt, bln rub |
|
|
4 989 |
4 793 |
4 793 |
4 664 |
4 664 |
|
4 560 |
|
Cash, bln rub |
|
|
410.4 |
113.1 |
113.1 |
252.3 |
252.3 |
|
94.0 |
|
Net debt, bln rub |
|
|
4 579 |
4 680 |
4 680 |
4 412 |
4 412 |
|
4 466 |
|
|
Ordinary share price, rub |
|
|
9.99 |
22.1 |
22.1 |
21.8 |
21.8 |
|
24.8 |
|
Number of ordinary shares, mln |
|
|
137.0 |
320.8 |
137.0 |
324.0 |
324.0 |
|
326.6 |
|
|
Market cap, bln rub |
|
|
1 369 |
7 089 |
3 028 |
7 063 |
7 063 |
|
8 086 |
|
EV, bln rub |
? |
|
5 947 |
11 769 |
7 707 |
11 475 |
11 475 |
|
12 552 |
|
Book value, bln rub |
|
|
-4 876 |
-5 044 |
-5 044 |
-4 536 |
-4 536 |
|
-4 398 |
|
|
EPS, rub |
? |
|
-6.92 |
-0.35 |
-0.82 |
-0.18 |
-0.48 |
|
-0.24 |
|
FCF/share, rub |
|
|
-1.22 |
1.06 |
2.48 |
1.30 |
1.30 |
|
1.84 |
|
BV/share, rub |
|
|
-35.6 |
-15.7 |
-36.8 |
-14.0 |
-14.0 |
|
-13.5 |
|
|
EBITDA margin, % |
? |
|
-509.6% |
46.4% |
22.3% |
26.1% |
26.1% |
|
38.8% |
|
Net margin, % |
? |
|
-481.5% |
-3.63% |
-3.63% |
-1.65% |
-4.44% |
|
-2.14% |
|
FCF yield, % |
? |
|
-12.2% |
4.79% |
11.2% |
5.95% |
5.95% |
|
7.45% |
|
ROE, % |
? |
|
-28.8% |
-3.45% |
-3.45% |
-1.75% |
-4.72% |
|
-2.35% |
|
ROA, % |
? |
|
-9.38% |
-1.11% |
-1.11% |
-0.58% |
-1.56% |
|
-0.80% |
|
|
P/E |
? |
|
-1.44 |
-63.2 |
-27.0 |
-123.1 |
-45.7 |
|
-104.5 |
|
P/FCF |
|
|
-8.20 |
20.9 |
8.91 |
16.8 |
16.8 |
|
13.4 |
|
P/S |
? |
|
6.95 |
2.29 |
0.98 |
2.03 |
2.03 |
|
2.24 |
|
P/BV |
? |
|
-0.28 |
-1.41 |
-0.60 |
-1.56 |
-1.56 |
|
-1.84 |
|
EV/EBITDA |
? |
|
-5.93 |
8.21 |
11.2 |
12.6 |
12.6 |
|
8.95 |
|
Debt/EBITDA |
|
|
-4.57 |
3.27 |
6.78 |
4.86 |
4.86 |
|
3.19 |
|
|
R&D/CAPEX, % |
|
|
88.9% |
92.1% |
92.1% |
100.6% |
100.6% |
|
56.5% |
|
|
CAPEX/Revenue, % |
|
|
6.61% |
7.97% |
7.97% |
7.94% |
7.94% |
|
14.4% |
|
| Change Healthcare shareholders |
